Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Gossamer Bio Inc. Stock

Price
Target price
€0.73

€0.73

5.720%
0.0395
5.720%
€3.00

€3.00

 
Buy 2 Sell 0
Buy 2
Sell 0
06.05.24 / Tradegate WKN: A2PCBS / Name: Gossamer Bio Inc. / Stock / ? /
Latest predictions
€3.00
26.03.24
-36.39%
buy
€3.00
22.07.23
-43.88%
buy
Show more
Your prediction
Pros and Cons of Gossamer Bio Inc. in the next few years
Wizard

Gossamer Bio Inc. Stock

A very strong showing by Gossamer Bio Inc. today, with an increase of €0.040 (5.720%) compared to yesterday's price.
The community is currently still undecided about Gossamer Bio Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of 3 € there is potential for a 313.51% increase which would mean more than doubling the current price of 0.73 € for Gossamer Bio Inc..
So far the community has only identified positive things for Gossamer Bio Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
What does Gossamer Bio Inc. do?

Pros and Cons of Gossamer Bio Inc. in the next few years

Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-27

Gossamer Bio Inc., a company in the biotechnology industry, exhibits financials that raise both concerns and opportunities for investors. A quick glance at the company's financial statements shows a pattern of increasing losses and negative stockholder equity. However, diving deeper into the details may help uncover valuable insights that could shape investment decisions regarding this company.

Increased total assets: The company's total assets have been gradually increasing over the years, from $539.43 million in 2020 to $343.66 million in 2021 and $272.45 million in 2022. This growth may signify an expansion in the company's resources and investments.

Rising research and development (R&D) expenses: Gossamer Bio continues to allocate a significant portion of its resources to R&D, indicating a commitment to product innovation. R&D expenses increased from $160.85 million in 2020 to $170.27 million in 2021 and $170.92 million in 2022. This trend suggests that the company is focused on developing its product pipeline.

Show more
Register To Post